Turitz Andrew
Known title: SVP - BUSINESS DEVELOPMENTCIK: 0001726221
Associated companies
Transaction History
| TDOC | ▼ Sell | Open Market | 20,773 | $151K | 9/4/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 1,617 | $12K | 9/3/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,348 | — | 8/30/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,056 | — | 8/30/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 3,100 | — | 8/30/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 1,627 | $18K | 6/3/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,056 | — | 5/31/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,348 | — | 5/31/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 3,100 | — | 5/31/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 5,647 | $82K | 3/5/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 6,190 | $90K | 3/4/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 475 | $7K | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 4,226 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 437 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 867 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,348 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 12,400 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,148 | — | 3/1/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 397 | $8K | 12/4/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,347 | — | 12/1/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 396 | $9K | 9/5/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,347 | — | 9/1/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 386 | $9K | 6/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,347 | — | 6/1/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 1,795 | $47K | 3/3/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 437 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,147 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,048 | — | 3/2/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 1,801 | $46K | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,205 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 515 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 867 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,389 | — | 3/1/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 1,334 | $89K | 3/7/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,974 | — | 3/4/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,567 | — | 3/4/2022 | View on chart |
| TDOC | ▼ Sell | Open Market | 1,754 | $123K | 3/3/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 868 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,147 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 1,205 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,050 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 515 | — | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Teladoc Launches AI-Powered Remote Monitoring Tools
Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.
Teladoc Launches AI-Powered Remote Monitoring Tools. Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.